Search Results - F/LOSS~

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /

    Published 2016
    Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
    Get full text
    Series
    Electronic Video
  5. 5

    The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /

    Published 2016
    Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
    Get full text
    Series
    Electronic Video
  6. 6

    The dynamic interactions between cellular-molecular physiology and the environment part 3, Case studies in pathophysiology : how to exploit cellular-molecular evolution /

    Published 2016
    Table of Contents: “…Contents: Simplification of structure and function as reverse evolution -- Chronic diseases & pathologies in different tissues and organs -- Breakdown in cell-cell communication -- Fibrosis & PPARɣ agonists -- Sensing loss of homeostasis & cellular perturbations.…”
    Get full text
    Series
    Electronic Video
  7. 7

    Pathways regulating bone resorption

    Published 2015
    Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
    Get full text
    Series
    Electronic Video
  8. 8

    Pathways regulating bone resorption

    Published 2015
    Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
    Get full text
    Series
    Electronic Video
  9. 9

    Pathways regulating bone resorption

    Published 2015
    Table of Contents: “…Contents: Formation and activation of osteoclasts -- Osteoporotic bone architecture -- Osteoclastic bone resorption -- Osteoclast motility and its inhibition -- Osteoclast regulation (hormones & other important factors) -- The role of low pH (acidosis) in bone loss -- Hypoxia & control of bone cell function by oxygen tension.…”
    Get full text
    Series
    Electronic Video
  10. 10

    The epidermis and its barrier(s)

    Published 2014
    Table of Contents: “…Contents: The importance of the skin barrier and its components -- The stratum corneum and the brick- and- mortar analogy -- Differentiation & programmed cell death of keratinocytes -- Lamellar bodies and their contents -- Barrier and moisturization -- Stratum corneum lipids and enzymes -- Epidermal tight junctions -- Measurement of trans-epidermal water loss (TEWL) -- Skin pigmentation, UV protection and P53 -- Immune barrier (Langerhans cells, Langerin & Birbek granules) -- Hair follicles (anti-microbial barrier and a route for skin penetration) -- Transdermal drug delivery -- Barrier homeostasis/up-regulation of properties -- Aves & mammals: liquid sequestration differences -- Adaptive plasticity of human skin barrier.…”
    Get full text
    Series
    Electronic Video
  11. 11

    Adapting proteostasis to ameliorate aggregation-associated amyloid diseases

    Published 2018
    Table of Contents: “…Contents: Protein folding, misfolding, aggregation -- The proteostasis network and its regulation -- Gain and loss of function diseases -- The transthyretin (TTR) amyloidosis -- Kinetic stabilizers & clinical trial results -- Tafamidis & Diflunisal: evidence for the amyloid hypothesis -- Improving protein misfolding/aggregation diseases -- The unfolded protein response (UPR) and its arm-selective activators -- ATF6 activation & reduction of TTR mutant -- Clinical trials in amyloidosis with cardiac involvement.…”
    Get full text
    Series
    Electronic Video
  12. 12

    Adapting proteostasis to ameliorate aggregation-associated amyloid diseases

    Published 2018
    Table of Contents: “…Contents: Protein folding, misfolding, aggregation -- The proteostasis network and its regulation -- Gain and loss of function diseases -- The transthyretin (TTR) amyloidosis -- Kinetic stabilizers & clinical trial results -- Tafamidis & Diflunisal: evidence for the amyloid hypothesis -- Improving protein misfolding/aggregation diseases -- The unfolded protein response (UPR) and its arm-selective activators -- ATF6 activation & reduction of TTR mutant -- Clinical trials in amyloidosis with cardiac involvement.…”
    Get full text
    Series
    Electronic Video
  13. 13

    Adapting proteostasis to ameliorate aggregation-associated amyloid diseases

    Published 2018
    Table of Contents: “…Contents: Protein folding, misfolding, aggregation -- The proteostasis network and its regulation -- Gain and loss of function diseases -- The transthyretin (TTR) amyloidosis -- Kinetic stabilizers & clinical trial results -- Tafamidis & Diflunisal: evidence for the amyloid hypothesis -- Improving protein misfolding/aggregation diseases -- The unfolded protein response (UPR) and its arm-selective activators -- ATF6 activation & reduction of TTR mutant -- Clinical trials in amyloidosis with cardiac involvement.…”
    Get full text
    Series
    Electronic Video
  14. 14

    Vitiligo in vivo and in vitro evidence for epidermal ROS/RNS-mediated regulation/dysregulation /

    Published 2014
    Table of Contents: “…Contents: Role of inherited vs. induced (tanning) skin colour -- Enhanced pigmentation after sun exposure -- Vitiligo and its characteristics (inherited skin colour loss) -- Correct diagnosis of vitiligo via characteristic fluorescence -- Use of Wood's light for differential diagnosis -- Cause and pathogenesis of vitiligo -- Oxidation and nitration of proteins and peptides in vitiligo and their effects -- DNA damage, T-cell response & p53 in vitiligo -- Treating vitiligo: Reducing oxidation and repigmentation.…”
    Get full text
    Series
    Electronic Video
  15. 15

    Vitiligo in vivo and in vitro evidence for epidermal ROS/RNS-mediated regulation/dysregulation /

    Published 2014
    Table of Contents: “…Contents: Role of inherited vs. induced (tanning) skin colour -- Enhanced pigmentation after sun exposure -- Vitiligo and its characteristics (inherited skin colour loss) -- Correct diagnosis of vitiligo via characteristic fluorescence -- Use of Wood's light for differential diagnosis -- Cause and pathogenesis of vitiligo -- Oxidation and nitration of proteins and peptides in vitiligo and their effects -- DNA damage, T-cell response & p53 in vitiligo -- Treating vitiligo: Reducing oxidation and repigmentation.…”
    Get full text
    Series
    Electronic Video
  16. 16

    Vitiligo in vivo and in vitro evidence for epidermal ROS/RNS-mediated regulation/dysregulation /

    Published 2014
    Table of Contents: “…Contents: Role of inherited vs. induced (tanning) skin colour -- Enhanced pigmentation after sun exposure -- Vitiligo and its characteristics (inherited skin colour loss) -- Correct diagnosis of vitiligo via characteristic fluorescence -- Use of Wood's light for differential diagnosis -- Cause and pathogenesis of vitiligo -- Oxidation and nitration of proteins and peptides in vitiligo and their effects -- DNA damage, T-cell response & p53 in vitiligo -- Treating vitiligo: Reducing oxidation and repigmentation.…”
    Get full text
    Series
    Electronic Video
  17. 17

    Metabolic and biochemical alterations in Alzheimer's disease facts and fictions /

    Published 2011
    Table of Contents: “…Contents: What causes selective neuronal loss in AD? -- Tauist and BAPtist hypothesis of AD -- Pathology and oxidative stress relationship -- NFT and amyloid-beta -- Stress-activated protein kinases and phospho-tau -- Amyloid-targeted approaches are unsuccessful -- Amyloid-beta controls redox activity -- Genetic factors are related to oxidative stress -- Therapeutics -- Potential mechanism of ROS generation -- Oxidative modifications and macromolecules -- Oxidative damage directly correlates with mtDNA -- Abnormal mitochondrial distribution in AD brains -- Iron histochemistry -- Antioxidant diet is protective -- Only one non-amyloid drug in phase III: 2010 -- Oxidative stress is necessary but not sufficient -- CaMKII-MYC mice -- Oxidative stress and cell cycle abnormalities -- Early stages of AD disease signals.…”
    Get full text
    Series
    Electronic Video
  18. 18

    The epidermis and its barrier(s)

    Published 2014
    Table of Contents: “…Contents: The importance of the skin barrier and its components -- The stratum corneum and the brick- and- mortar analogy -- Differentiation & programmed cell death of keratinocytes -- Lamellar bodies and their contents -- Barrier and moisturization -- Stratum corneum lipids and enzymes -- Epidermal tight junctions -- Measurement of trans-epidermal water loss (TEWL) -- Skin pigmentation, UV protection and P53 -- Immune barrier (Langerhans cells, Langerin & Birbek granules) -- Hair follicles (anti-microbial barrier and a route for skin penetration) -- Transdermal drug delivery -- Barrier homeostasis/up-regulation of properties -- Aves & mammals: liquid sequestration differences -- Adaptive plasticity of human skin barrier.…”
    Get full text
    Series
    Electronic Video
  19. 19

    Metabolic and biochemical alterations in Alzheimer's disease facts and fictions /

    Published 2011
    Table of Contents: “…Contents: What causes selective neuronal loss in AD? -- Tauist and BAPtist hypothesis of AD -- Pathology and oxidative stress relationship -- NFT and amyloid-beta -- Stress-activated protein kinases and phospho-tau -- Amyloid-targeted approaches are unsuccessful -- Amyloid-beta controls redox activity -- Genetic factors are related to oxidative stress -- Therapeutics -- Potential mechanism of ROS generation -- Oxidative modifications and macromolecules -- Oxidative damage directly correlates with mtDNA -- Abnormal mitochondrial distribution in AD brains -- Iron histochemistry -- Antioxidant diet is protective -- Only one non-amyloid drug in phase III: 2010 -- Oxidative stress is necessary but not sufficient -- CaMKII-MYC mice -- Oxidative stress and cell cycle abnormalities -- Early stages of AD disease signals.…”
    Get full text
    Series
    Electronic Video
  20. 20

    Metabolic and biochemical alterations in Alzheimer's disease facts and fictions /

    Published 2011
    Table of Contents: “…Contents: What causes selective neuronal loss in AD? -- Tauist and BAPtist hypothesis of AD -- Pathology and oxidative stress relationship -- NFT and amyloid-beta -- Stress-activated protein kinases and phospho-tau -- Amyloid-targeted approaches are unsuccessful -- Amyloid-beta controls redox activity -- Genetic factors are related to oxidative stress -- Therapeutics -- Potential mechanism of ROS generation -- Oxidative modifications and macromolecules -- Oxidative damage directly correlates with mtDNA -- Abnormal mitochondrial distribution in AD brains -- Iron histochemistry -- Antioxidant diet is protective -- Only one non-amyloid drug in phase III: 2010 -- Oxidative stress is necessary but not sufficient -- CaMKII-MYC mice -- Oxidative stress and cell cycle abnormalities -- Early stages of AD disease signals.…”
    Get full text
    Series
    Electronic Video